Synergistic inhibition of natural killer cells by the nonsignaling molecule CD94

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 42, 2013, Pages 16981-16986

  Cheent, Kuldeep S ^a   Jamil, Khaleel M ^a   Cassidy, Sorcha ^a   Liu, Mengya ^b   Mbiribindi, Berenice ^b   Mulder, Arend ^c   Claas, Frans H J ^c   Purbhoo, Marco A ^a   Khakoo, Salim I ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Innate immunity; Mhc I peptides

Indexed keywords

CD94 ANTIGEN; HLA E ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2A; PEPTIDE; SIGNAL PEPTIDE;

ANTIGEN PRESENTATION; ARTICLE; CELL FUNCTION; CELL ISOLATION; CELL LINE; DOWN REGULATION; ENZYME INHIBITION; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOLOGICAL SYNAPSE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOICHIOMETRY;

INNATE IMMUNITY; MHC-I PEPTIDES;

HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; JURKAT CELLS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY C; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY D; PEPTIDES; RECEPTORS, KIR;

EID: 84885717926     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1304366110     Document Type: Article

References (41)

1. Lanier LL (2008) Up on the tightrope: Natural killer cell activation and inhibition. Nat Immunol 9(5): 495-502.
2. Parham P, et al. (2010) Primate-specific regulation of natural killer cells. J Med Primatol 39(4): 194-212.
3. Shum BP, et al. (2002) Conservation and variation in human and common chimpanzee CD94 and NKG2 genes. J Immunol 168(1): 240-252.
4. Guethlein LA, Flodin LR, Adams EJ, Parham P (2002) NK cell receptors of the orangutan (Pongo pygmaeus): A pivotal species for tracking the coevolution of killer cell Iglike receptors with MHC-C. J Immunol 169(1): 220-229.
5. Vance RE, Kraft JR, Altman JD, Jensen PE, Raulet DH (1998) Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b). J Exp Med 188(10): 1841-1848.
6. Vance RE, Raulet DH (1998) Toward a quantitative analysis of the repertoire of class I MHC-specific inhibitory receptors on natural killer cells. Curr Top Microbiol Immunol 230: 135-160.
7. Martin MP, et al. (2002) Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 31(4): 429-434.
8. Alter G, et al. (2007) Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. J Exp Med 204(12): 3027-3036.
9. Khakoo SI, et al. (2004) HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305(5685): 872-874.
10. Romero V, et al. (2008) Interaction of NK inhibitory receptor genes with HLA-C and MHC class II alleles in Hepatitis C virus infection outcome. Mol Immunol 45(9): 2429-2436.
11. Golden-Mason L, et al.; Virahep-C Study Group (2011) Natural killer inhibitory receptor expression associated with treatment failure and interleukin-28B genotype in patients with chronic hepatitis C. Hepatology 54(5): 1559-1569.
12. Zhang R, et al. (2007) Increased NKG2A found in cytotoxic natural killer subset in HIV-1 patients with advanced clinical status. AIDS 21(Suppl 8):S9-S17.
13. Brooks CR, Elliott T, Parham P, Khakoo SI (2006) The inhibitory receptor NKG2A determines lysis of vaccinia virus-infected autologous targets by NK cells. J Immunol 176(2): 1141-1147.
14. Fang M, et al. (2011) CD94 is essential for NK cell-mediated resistance to a lethal viral disease. Immunity 34(4): 579-589.
15. Cohen GB, et al. (1999) The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 10(6): 661-671.
16. Malnati MS, et al. (1995) Peptide specificity in the recognition of MHC class I by natural killer cell clones. Science 267(5200): 1016-1018.
17. Rajagopalan S, Long EO (1997) The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity. J Exp Med 185(8): 1523-1528.
18. Rajagopalan S, Long EO (2010) Antagonizing inhibition gets NK cells going. Proc Natl Acad Sci USA 107(23): 10333-10334.
19. Fadda L, et al. (2010) Peptide antagonism as a mechanism for NK cell activation. Proc Natl Acad Sci USA 107(22): 10160-10165.
20. Borhis G, et al. (2013) A peptide antagonist disrupts NK cell inhibitory synapse formation. J Immunol 190(6): 2924-2930.
21. Llano M, et al. (1998) HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: Preferential response to an HLA-G-derived nonamer. Eur J Immunol 28(9): 2854-2863.
22. Petrie EJ, et al. (2008) CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence. J Exp Med 205(3): 725-735.
23. Kaiser BK, Pizarro JC, Kerns J, Strong RK (2008) Structural basis for NKG2A/CD94 recognition of HLA-E. Proc Natl Acad Sci USA 105(18): 6696-6701.
24. Ulbrecht M, Modrow S, Srivastava R, Peterson PA, Weiss EH (1998) Interaction of HLA-E with peptides and the peptide transporter in vitro: Implications for its function in antigen presentation. J Immunol 160(9): 4375-4385.
25. Nattermann J, et al. (2005) HIV-1 infection leads to increased HLA-E expression resulting in impaired function of natural killer cells. Antivir Ther 10(1): 95-107.
26. Tomasec P, et al. (2000) Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 287(5455): 1031.
27. Nattermann J, et al. (2005) The HLA-A2 restricted T cell epitope HCV core 35-44 stabilizes HLA-E expression and inhibits cytolysis mediated by natural killer cells. Am J Pathol 166(2): 443-453.
28. Alter G, et al. (2011) HIV-1 adaptation to NK-cell-mediated immune pressure. Nature 476(7358): 96-100.
29. Valés-Gómez M, Reyburn HT, Erskine RA, López-Botet M, Strominger JL (1999) Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E. EMBO J 18(15): 4250-4260.
30. Martini F, Agrati C, D'Offizi G, Poccia F (2005) HLA-E up-regulation induced by HIV infection may directly contribute to CD94-mediated impairment of NK cells. Int J Immunopathol Pharmacol 18(2): 269-276.
31. Lazetic S, Chang C, Houchins JP, Lanier LL, Phillips JH (1996) Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J Immunol 157(11): 4741-4745.
32. Carretero M, et al. (1997) The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules. Eur J Immunol 27(2): 563-567.
33. Pérez-Villar JJ, et al. (1996) Biochemical and serologic evidence for the existence of functionally distinct forms of the CD94 NK cell receptor. J Immunol 157(12): 5367-5374.
34. Lampen MH, et al. (2013) Alternative peptide repertoire of HLA-E reveals a binding motif that is strikingly similar to HLA-A2. Mol Immunol 53(1-2): 126-131.
35. Boyington JC, et al. (1999) Structure of CD94 reveals a novel C-type lectin fold: Implications for the NK cell-associated CD94/NKG2 receptors. Immunity 10(1): 75-82.
36. Orr MT, et al. (2010) Development and function of CD94-deficient natural killer cells. PLoS ONE 5(12):e15184.
37. Long EO, Kim HS, Liu D, Peterson ME, Rajagopalan S (2013) Controlling natural killer cell responses: Integration of signals for activation and inhibition. Annu Rev Immunol 31: 227-258.
38. Davis DM, et al. (1999) The human natural killer cell immune synapse. Proc Natl Acad Sci USA 96(26): 15062-15067.
39. Schleinitz N, March ME, Long EO (2008) Recruitment of activation receptors at inhibitory NK cell immune synapses. PLoS ONE 3(9):e3278.
40. Kirwan SE, Burshtyn DN (2005) Killer cell Ig-like receptor-dependent signaling by Ig-like transcript 2 (ILT2/CD85j/LILRB1/LIR-1). J Immunol 175(8): 5006-5015.
41. Boyington JC, Motyka SA, Schuck P, Brooks AG, Sun PD (2000) Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand. Nature 405(6786): 537-543.